Skip to main content
SpringerLink
Log in

Nitinol coils for emphysema have high short-term costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2014 US dollars

  2. chronic obstructive pulmonary disease-related

References

  1. Deslee G, et al. Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema: The REVOLENS Randomized Clinical Trial. JAMA: the Journal of the American Medical Association 315: 175-84, No. 2, 12 Jan 2016. Available from: URL: http://doi.org/10.1001/jama.2015.17821

    Article  PubMed  Google Scholar 

  2. Sciurba FC, et al. Bronchoscopic Lung Volume Reduction in COPD: Lessons in Implementing Clinically Based Precision Medicine. JAMA: the Journal of the American Medical Association 315: 139-141, No. 2, 12 Jan 2016. Available from: URL: http://dx.doi.org/10.1001/jama.2015.17714

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nitinol coils for emphysema have high short-term costs. PharmacoEcon Outcomes News 745, 24 (2016). https://doi.org/10.1007/s40274-016-2765-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-2765-2

Search

Navigation